Target intelligence / Profile preview

Ciliogenesis-associated TTC17-interacting protein (CATIP)

Target
CATIP
Molecular classification
Other (intracellular structural/ciliogenesis-associated protein)
01

Overview

Ciliogenesis-associated TTC17-interacting protein (CATIP, gene symbol C2orf62) is a protein involved in the formation of primary cilia on cells by regulating actin filament dynamics and ciliogenesis[1][3][9]. It plays a critical role in the organization of the actin cytoskeleton, essential for cilium assembly and maintenance of sperm structure[3][5][7][9]. Pathogenic mutations in CATIP are linked to male infertility syndromes, particularly those involving abnormal sperm morphology and motility, such as oligoteratoasthenozoospermia (OTA) and spermatogenic failure 54, due to disrupted actin organization in sperm tails[1][5][9]. This protein does not directly fall into canonical categories such as receptor, enzyme, transporter, or transcription factor; instead, it is best classified as an intracellular structural/regulatory protein[9]. No known drugs, clinical biomarkers, or safety issues are currently associated with CATIP, and it is primarily of interest in rare genetic infertility disorders rather than as a therapeutic target[1][5][9].

Other names
C2orf62MGC50811Chromosome 2 open reading frame 62hypothetical protein LOC375307
02

Biological functions

CiliogenesisRegulation of actin cytoskeletonActin filament polymerizationSperm structure maintenance
03

Disease associations

Male infertility (including oligozoospermia, azoospermia, oligoteratoasthenozoospermia, spermatogenic failure)

Beyond the preview

Go deeper on Ciliogenesis-associated TTC17-interacting protein (CATIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciliogenesis-associated TTC17-interacting protein (CATIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call